{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:04:07Z","timestamp":1793037847730,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["NMUB20230108"],"award-info":[{"award-number":["NMUB20230108"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbi.2025.106086","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:55:12Z","timestamp":1755824112000},"page":"106086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Colonoscopic fecal microbiota transplantation for Mild-to-Moderate Parkinson\u2019s Disease: A randomized controlled trial"],"prefix":"10.1016","volume":"130","author":[{"given":"Jingyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangnong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.bbi.2025.106086_b0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.bbi.2025.106086_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global Trends in the Incidence, Prevalence, and Years Lived with Disability of Parkinson's Disease in 204 Countries\/Territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbi.2025.106086_b0015","doi-asserted-by":"crossref","unstructured":"GBD 2016 Parkinson's Disease Collaborators (2018). Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, 17(11), 939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3.","DOI":"10.1016\/S1474-4422(18)30295-3"},{"issue":"7","key":"10.1016\/j.bbi.2025.106086_b0020","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"The Lancet. Healthy Longevity"},{"issue":"4","key":"10.1016\/j.bbi.2025.106086_b0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease","volume":"29","author":"Berg","year":"2014","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"10291","key":"10.1016\/j.bbi.2025.106086_b0030","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (london, England)"},{"issue":"4","key":"10.1016\/j.bbi.2025.106086_b0035","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3233\/JPD-212707","article-title":"Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota","volume":"11","author":"Yemula","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.bbi.2025.106086_b0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2025.106086_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.70029","article-title":"The Gut-Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications","author":"Menozzi","year":"2025","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/j.bbi.2025.106086_b0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","article-title":"Probiotics for constipation and gut microbiota in Parkinson's disease","volume":"103","author":"Du","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbi.2025.106086_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2024.103045","article-title":"Efficacy of probiotic supplements on Parkinson's disease: a systematic review and meta-analysis","volume":"82","author":"Jin","year":"2024","journal-title":"Complement. Ther. Med."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","article-title":"An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants","volume":"14","author":"Hall","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson's disease","volume":"10","author":"Kwon","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"5","key":"10.1016\/j.bbi.2025.106086_b0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41430-024-01411-1","article-title":"Effects of dietary supplements, foods, and dietary patterns in Parkinson's disease: meta-analysis and systematic review of randomized and crossover studies","volume":"78","author":"Wu","year":"2024","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.bbi.2025.106086_b0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.irn.2025.03.004","article-title":"Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson's disease (PD)","volume":"180","author":"Kumar","year":"2025","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson's disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.bbi.2025.106086_b0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.29300","article-title":"Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome","volume":"38","author":"Boktor","year":"2023","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"11","key":"10.1016\/j.bbi.2025.106086_b0090","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1111\/ene.15671","article-title":"Gut microbiota dysbiosis in Parkinson disease: a systematic review and pooled analysis","volume":"30","author":"Kleine Bardenhorst","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2025.106086_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112444","article-title":"Association between increased and decreased gut microbiota abundance and Parkinson's disease: a systematic review and subgroup meta-analysis","volume":"191","author":"Bai","year":"2024","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41531-024-00724-z","article-title":"Meta-analysis of shotgun sequencing of gut microbiota in Parkinson's disease","volume":"10","author":"Nishiwaki","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"17","key":"10.1016\/j.bbi.2025.106086_b0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037960","article-title":"Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson's disease","volume":"103","author":"Liu","year":"2024","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.bbi.2025.106086_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bbi.2025.106086_b0115","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ijms24021001","article-title":"The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: a Review","volume":"24","author":"Matheson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.106086_b0120","doi-asserted-by":"crossref","unstructured":"Minkoff, N. Z., Aslam, S., Medina, M., Tanner-Smith, E. E., Zackular, J. P., Acra, S., Nicholson, M. R., & Imdad, A. (2023). Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). The Cochrane database of systematic reviews, 4(4), CD013871. https:\/\/doi.org\/10.1002\/14651858.CD013871.pub2.","DOI":"10.1002\/14651858.CD013871.pub2"},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0125","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41598-024-82139-7","article-title":"Alpha synuclein overexpression can drive microbiome dysbiosis in mice","volume":"15","author":"Sampson","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbi.2025.106086_b0130","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1021\/acschembio.4c00095","article-title":"Discovery of a Gut Bacterial Metabolic Pathway that Drives \u03b1-Synuclein Aggregation","volume":"19","author":"Ortiz de Ora","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbi.2025.106086_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.bbi.2025.106086_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson's disease-a randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2025.106086_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microbes"},{"issue":"9","key":"10.1016\/j.bbi.2025.106086_b0150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal Microbiota Transplantation for Treatment of Parkinson Disease: a Randomized Clinical Trial","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.bbi.2025.106086_b0155","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1016\/j.bbi.2025.106086_b0160","doi-asserted-by":"crossref","unstructured":"Cammarota, G., Ianiro, G., Tilg, H., Rajili\u0107-Stojanovi\u0107, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., Segal, J., Aloi, M., Masucci, L., Molinaro, A., Scaldaferri, F., Gasbarrini, G., Lopez-Sanroman, A., Link, A., de Groot, P., de Vos, W. M., \u2026 European FMT Working Group (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut, 66(4), 569\u2013580. https:\/\/doi.org\/10.1136\/gutjnl-2016-313017.","DOI":"10.1136\/gutjnl-2016-313017"},{"issue":"35","key":"10.1016\/j.bbi.2025.106086_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.bbi.2025.106086_b0170","series-title":"National Institute for Health and Care Research","article-title":"Determining the optimal route of faecal microbiota transplant in patients with ulcerative colitis: the STOP-Colitis pilot RCT","author":"Quraishi","year":"2024"},{"issue":"5","key":"10.1016\/j.bbi.2025.106086_b0175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JPD-249007","article-title":"A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson's Disease: getting it right, if not PARFECT","volume":"14","author":"Beckers","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","article-title":"Mechanisms of peripheral levodopa resistance in Parkinson's disease","volume":"8","author":"Beckers","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.bbi.2025.106086_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1046910","article-title":"A review of studies on gut microbiota and levodopa metabolism","volume":"14","author":"Zhong","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0190","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1038\/s41598-019-45173-4","article-title":"A Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation","volume":"9","author":"Burz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106086_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8266793","article-title":"A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease","volume":"2022","author":"Tan","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation","volume":"20","author":"Kuai","year":"2021","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.bbi.2025.106086_b0205","article-title":"Implications of gut microbiota dysbiosis and fecal metabolite changes in psychologically stressed mice","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106086_b0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12866-023-03123-1","article-title":"Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Microbiol."},{"issue":"3","key":"10.1016\/j.bbi.2025.106086_b0215","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00415-021-10567-w","article-title":"Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation","volume":"269","author":"Metta","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2025.106086_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1479343","article-title":"Gut microbiota and Parkinson's disease: potential links and the role of fecal microbiota transplantation","volume":"16","author":"Feng","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.bbi.2025.106086_b0225","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.cell.2021.03.022","article-title":"SnapShot: the microbiota-gut-brain axis","volume":"184","author":"Agirman","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.106086_b0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13578-015-0018-x","article-title":"Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway","volume":"5","author":"Lau","year":"2015","journal-title":"Cell Biosci."},{"issue":"8","key":"10.1016\/j.bbi.2025.106086_b0235","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nchembio.2007.13","article-title":"A new thiamin salvage pathway","volume":"3","author":"Jenkins","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"22","key":"10.1016\/j.bbi.2025.106086_b0240","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.3390\/ijms20225797","article-title":"B Vitamins and Fatty Acids: what do they Share with Small Vessel Disease-Related Dementia?","volume":"20","author":"Moretti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.106086_b0245","doi-asserted-by":"crossref","unstructured":"Lu'o'ng, K.v, & Nguy\u00ean, L. T. (2012). Thiamine and Parkinson's disease. Journal of the neurological sciences, 316(1-2), 1\u20138. https:\/\/doi.org\/10.1016\/j.jns.2012.02.008.","DOI":"10.1016\/j.jns.2012.02.008"},{"issue":"10","key":"10.1016\/j.bbi.2025.106086_b0250","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s43587-023-00501-2","article-title":"An emerging biomarker for dopaminergic cell loss","volume":"3","author":"Verbeek","year":"2023","journal-title":"Nat. Aging"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:39:54Z","timestamp":1772811594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125003216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0889159125003216"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106086","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colonoscopic fecal microbiota transplantation for Mild-to-Moderate Parkinson\u2019s Disease: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106086"}}